Answers are grounded in this paper and cite their sources.
The residual efficacy of VECTRON™ T500 extended for 12 months post-spraying, effectively covering the full malaria transmission season while maintaining high mortality rates in pyrethroid-resistant malaria vectors. VECTRON™ T500 demonstrated non-inferiority in performance compared to Actellic® 300CS, the standard reference product. This new IRS formulation has the potential to play a crucial role in managing insecticide resistance by being integrated into a rotational strategy alongside other IRS products containing insecticides with different modes of action.
No takes yet. Share an insight, caveat, or question.
Hien et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: